mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
UNICANCER
University of Chicago
University Hospital Schleswig-Holstein
Ludwig Institute for Cancer Research
Case Comprehensive Cancer Center
Hoosier Cancer Research Network
University of Nebraska
Alliance for Clinical Trials in Oncology
Fox Chase Cancer Center
Translational Oncology Research International
Alliance for Clinical Trials in Oncology
AIO-Studien-gGmbH
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
University of Miami
Roswell Park Cancer Institute
UNICANCER
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
University of Chicago
Northwestern University